The Strattera brand of medication is designed to treat Attention Deficit Hyperactivity Disorder (ADHD). It contains the same active ingredient as Strattera, atomoxetine.
ADHD can be treated in a variety of ways. Treatment is best for those who have trouble paying attention. Treatment with atomoxetine may help improve the ability to pay attention, while other forms of medication are used for different types of ADHD.
The most common type of medication is the stimulant. This is a group of drugs that help get and release chemicals in the brain that help get attention. For example, can help improve focus in children who show difficulty paying attention and hyperactivity.
A medication is usually used in a group of people with ADHD.
Strattera is a brand of medication called, a drug that is used to treat ADHD. The active ingredient in Strattera is atomoxetine.
The medication is in a group of drugs called selective norepinephrine reuptake inhibitors, or norepinephrine reuptake inhibitors. These medications increase the level of norepinephrine in the brain. This increase is thought to help improve attention and reduce hyperactivity.
The drug is usually taken orally, with or without food, in a dose of 50 mg. The dose of medication that works is usually the same. It is important that the medication be taken at the same time each day, or as directed by a doctor.
The medication is taken by mouth. The medication is usually given by a person with or without food. This means that the person who is taking the medication will have to wait at least 1 hour before a meal that contains the drug. The meal will determine how the medication is being given.
The medication is usually taken by mouth with or without water. The medication is usually given by a person with ADHD.
Strattera is available without a prescription from a doctor. The medication may be available as a capsule. The medication may also be available as a tablet. The medication is usually taken by mouth once daily.
Strattera works by increasing the levels of norepinephrine in the brain. This brain chemical helps get and release chemicals in the brain. Strattera is in a group of drugs called norepinephrine reuptake inhibitors.
Norepinephrine is a neurotransmitter that is produced in the brain. Norepinephrine helps to get and release norepinephrine.
Strattera increases the level of norepinephrine in the brain. This increases the amount of norepinephrine that the brain can produce. This helps to get and release a chemical called serotonin. The medication may also help to increase the level of serotonin in the brain. This increases the amount of the chemical that the brain can produce. This increase is thought to help get and release a chemical called dopamine. Dopamine is a chemical that is produced by the reward center of the brain and helps to get and release dopamine.
Strattera helps to increase the level of dopamine in the brain. This helps to get and release dopamine. Dopamine is a chemical that is released when the brain makes certain other chemicals. This increases the amount of dopamine in the brain. This helps to get and release chemicals in the brain.
Strattera works by increasing the level of norepinephrine in the brain.
It helps to get and release chemicals in the brain. Strattera increases the level of norepinephrine that the brain can produce.
Strattera may help to increase the amount of norepinephrine that the brain can produce.
Strattera is also known by the brand name Strattera.
Atomoxetine is a medication that is used to treat attention deficit hyperactivity disorder (ADHD) and behavior problems in children and adolescents (B Propalim et al, 2016). It is a selective norepinephrine reuptake inhibitor (SNRI), which means that it does not change the neurotransmitters that are involved in attention and behavior, such as dopamine and serotonin.
Atomoxetine was the first selective norepinephrine reuptake inhibitor (SNRI) to be approved for the treatment of ADHD. It was created because of its effectiveness in treating ADHD symptoms and has been proven to be safe and effective for many patients. It can be taken as a tablet, injection, or as a nasal spray, and it is typically used to treat ADHD in children.
Atomoxetine is usually started as a small dose in the therapeutic range and continued for a minimum of 3 days for the treatment of ADHD. Once the benefits of the medication have been seen, it is typically tapered and gradually increased based on the child’s response to the medication.
The medication works best when it is started in the therapeutic range and the medication is gradually titrated in order to see a maximum benefit. It is important to monitor the child and do not adjust the dose or stop the medication prematurely, as this could lead to the medication not working as intended.
It is important to know that this medication does not work for everyone, and it can cause side effects in some patients. If you are considering this medication for yourself, talk to your healthcare provider about your current medication, as they may have a specialist in your child’s treatment.
If you are considering this medication, tell your healthcare provider if you are using this medication or have recently taken it and if you are currently taking other medications, as they may be able to advise you on how to safely use this medication.
Remember that this medication has been approved for use in children by the Food and Drug Administration (FDA).
As with all medications, there is the possibility of side effects. If you experience any of the following symptoms while taking this medication, stop taking this medication and contact your healthcare provider immediately: difficulty breathing, chest pain, nausea, sweating, or dizziness. This medication may need to be stopped or increased in order to manage your child’s symptoms.
While taking this medication, there may be some side effects to be aware of. The side effects of Strattera may include:
These side effects may lessen as the medication is used more and more. If you experience any of the following symptoms, stop taking this medication and contact your healthcare provider immediately:
Brand name of Brand Name Atomoxetine (Strattera) is a medication that is used to treat ADHD, a condition in which the brain develops new chemicals to help you get and keep healthy.
Brand name of Brand Name Atomoxetine is a brand name of the following medications:
These are all medications that are manufactured by AstraZeneca, which is one of the largest pharmaceutical companies in the US. They are currently the subject of ongoing litigation in the US District Court for the Eastern District of Virginia. The litigants are also moving forward with settlements that could result in even higher pharmaceutical costs for AstraZeneca. If this happens to you, talk to your healthcare provider about whether you can use this medication for yourself.
Atomoxetine (Strattera) is available in several different dosage forms, including tablets, capsules, and oral suspensions.
is a drug used to treat adults, adolescents, and children with attention deficit hyperactivity disorder (ADHD). It can be used either on its own or with other psychostimulants. To increase alertness, concentration, and memory, it is also utilized as a cognitive enhancer.
Norepinephrine reuptake inhibitors like Strattera function by boosting norepinephrine levels in the brain and central nervous system. A neurotransmitter in the brain called norepinephrine helps to decrease impulsivity and hyperactivity while promoting focus and attention span. Most commonly, Strattera is used to treat ADHD, but it may have some off-label uses for anxiety hence raising the question:why is Strattera so expensive?
The Food and Drug Administration (FDA) authorized Strattera as the first and only non-stimulant medicine for the treatment of ADHD in the US. It was also the first non-stimulant drug to be authorized for the treatment of ADHD in adults.
Mild side effects that have been reported with Strattera include:
These side effects may be temporary, lasting a few days to weeks. This drug raises many side effects and the big question too: Why is Strattera so expensive?
Serious side effects that have been reported and their symptoms include:
Last Updated: March 18, 2025
Eli Lillyreported that it has been acquired by GlaxoSmithKline (GSK), the world's leading pharmaceutical company, for about $2.6 billion, bringing total revenue of $13.4 billion. The acquisition is expected to generate revenue growth of 2-3% during the next five years.
GSK said that the acquisition brings a premium on Lilly's $1 billion acquisition of Eli Lilly & Co. (Lilly), which makes the company's leading antidepressant drug, Strattera. The acquisition also brings a substantial revenue boost to Lilly's portfolio of in-house drug businesses, including the maker of the most widely used drug, Zyprexa, and the largest and most profitable biologic, Prozac.
The Lilly acquisition represents a significant milestone in Lilly's long-term effort to bring a new medication to patients who have lost their ability to tolerate the side effects of other prescription drugs.
Lilly's purchase represents another important milestone for Lilly, which had hoped to buy up the market share of Eli Lilly through a strategic transaction. The acquisition represents a significant milestone in Lilly's long-term effort to bring a new medication to patients who have lost their ability to tolerate the side effects of other prescription drugs.
During a conference call with analysts on January 5, 2023, Dr. Jane Thompson, Lilly's president of marketing, said that she has been impressed by the Lilly acquisition and noted that the acquisition offers a clear path forward in Lilly's long-term strategy to bring a new medication to patients who have lost their ability to tolerate other prescription drugs.
She further stated that Lilly's sales and marketing efforts have been focused on improving its products and increasing its revenue growth. Dr. Thompson further commented that the company's pipeline is well-positioned for successful growth in the years ahead.
"This acquisition is the cornerstone of Lilly's long-term strategy to bring new medicines to patients who have lost their ability to tolerate other prescription drugs," she added.
Follow Me on.
References
1. Lilly Scientific Inc. (Lilly, R)Medscape Medical News2023; (25)LillyRetrieved April 18, 2025, from https://www.leic-market.com/article/view/3749/33
2. GlaxoSmithKline Canada Inc. (GSK)GlaxoSmithKline Canada Inc3. Lilly, Eli Lilly and Company (Lilly, R)4.
5.6.7.8.
Stade de France Pharmacy